Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Aug 15, 2022; 14(8): 1540-1551
Published online Aug 15, 2022. doi: 10.4251/wjgo.v14.i8.1540
Published online Aug 15, 2022. doi: 10.4251/wjgo.v14.i8.1540
Figure 1 Kaplan-Meier curve for overall survival and relapse-free survival between patients in chemoradiotherapy group and chemo therapy group.
A and B: summarizes the overall survival (OS) and relapse-free survival (RFS) survival curves of the chemoradiotherapy (CRT) group and chemotherapy (CT) group for all patients; C and D: summarizes the OS and RFS survival curves of the CRT group and CT group for Siewert type II gastroesophageal junction (AGE) patients; E and F: summarizes the OS and RFS survival curves of the CRT group and CT group for Siewert type III AGE patients).
- Citation: Kang WZ, Shi JM, Wang BZ, Xiong JP, Shao XX, Hu HT, Jin J, Tian YT. Adjuvant chemoradiotherapy vs adjuvant chemotherapy in locally advanced Siewert type II/III adenocarcinoma of gastroesophageal junction after D2/R0 resection. World J Gastrointest Oncol 2022; 14(8): 1540-1551
- URL: https://www.wjgnet.com/1948-5204/full/v14/i8/1540.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i8.1540